Clinical Scorecard: Isolated Closure or Restriction of the Prenatal Foramen Ovale Manifesting Postnatally: A Unique and Often Overlooked Clinical Condition
At a Glance
Category
Detail
Condition
Isolated prenatal foramen ovale closure or restriction
Key Mechanisms
Persistent pulmonary hypertension of the newborn (PPHN) and impaired left ventricular function
Target Population
Neonates diagnosed postnatally with isolated FO closure or restriction
Care Setting
Tertiary neonatal intensive care unit
Key Highlights
Median gestational age of affected neonates was 39 weeks.
Common presentations included cyanosis and respiratory distress.
Echocardiography revealed impaired left ventricular function with preserved right ventricular function.
Management included prostaglandin infusion and pulmonary arterial hypertension therapy.
Survivors showed normalization of left ventricular function within 1–4 days.
Guideline-Based Recommendations
Diagnosis
Echocardiographic evidence of FO closure or restriction.
Exclusion of infection, pulmonary disease, and congenital heart defects.
Management
Prostaglandin infusion to maintain ductus arteriosus patency.
Inotropic support and pulmonary arterial hypertension therapy.
Monitoring & Follow-up
Assessment of left and right ventricular contractility.
Monitoring of troponin T and NT-pro BNP levels.
Risks
Potential for severe neonatal PPHN and left ventricular failure.
Risk of global developmental delay in survivors.
Patient & Prescribing Data
Neonates with isolated prenatal FO closure or restriction diagnosed postnatally.
Inotropic support and pulmonary arterial hypertension therapy are critical for management.
Clinical Best Practices
Early recognition of isolated FO closure or restriction is essential.
Careful evaluation of the interatrial septum is recommended.
Regular echocardiographic follow-up to monitor cardiac function.
